약수터2호최종2-웹용
|
|
|
- 서준 순
- 5 years ago
- Views:
Transcription
1
2
3
4 Contents
5
6
7
8 06
9 07
10 08
11 é 09
12
13
14 12
15 13
16 14
17 15
18 16
19 17
20 18
21 19
22 20
23 21
24
25
26 24
27 25
28 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients 12) Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study 24) Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE Study 25) 26 Adverse Drug Events in Pediatric Outpatients 26) Adverse Drug Events in Adult Patients Leading to Emergency Department Visits 27) Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data 28)
29 Hospital admissions for dru g-induceddisorders in England: a study using the Hospital Episodes Statistics(HES) database 29) Adverse Drug Events in the Outpatient Setting: An 11-Year National Analysis 11) National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events in Children and Adolescents 30) Prevalence of Adverse Drug Events in Ambulatory Care: A Systematic Review 31) Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. 15) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. 10) 27 é ö
30 28
31 29
32 30
33 31
34 32
35 33
36 34
37 1,531 25, ,148 1,469 30, , , (14) (46) (272) (521)
38 36
39 37
40 38
41 3 (3-4) 13 (11-15) 0 (0%) 1 (0.4%) 8 (14%) 26 (11%) 49 (86%) 199 (88%) 17 (30%) 69 (31%) 11 (19%) 111 (49%) 7 (12%) 0 (0%) 6 (11%) 34 (15%) 4 (7%) 0 (0%) 3 (5%) 0 (0%) 3 (5%) 1 (0.4%) 39 2 (4%) 3 (1%)
42 15 (26.0%) 123 (54.0%) 6 (11.0%) 6 (3.0%) 4 (7.0%) 1 (0.4%) 4 (7.0%) 2 (1.0%) 3 (5.0%) (5.0%) 16 (7.0%) 3 (5.0%) 18 (8.0%) 3 (5.0%) 13 (6.0%) 2 (4.0%) 6 (3.0%)
43 41
44 42
45 55 2.4( ) ( ) ( ) ( ) ( ) ( ) 43 6(22.2) 21(77.8) 27 10(35.7) 18(64.3) (29.1) 39(70.9) 55
46 44
47 45
48 46
49
50 48
51 % 9, % 14, % 14, % 18, % 17, % 0.22% 36, % 34, % 34, % 30, % 31, % 0.08% 13, % 14, % 13, % 16, % 10, % 0.04% 6, % 5, % 4, % 4, % 4, % 0.14% 22, % 24, % 27, % 30, % 34, % 1.09% 181, % 179, % 175, % 187, % 218, % % 490, % 469, % 474, % 509, % 482, % 4.58% 760, % 742, % 744, % 798, % 800, % 16,598,546 15,127,645 14,989,953 15,181,779 15,559,359
52 % 101, % 121, % 126, % 136, % 155, % 2.78% 460, % 383, % 371, % 374, % 356, % 0.24% 39, % 34, % 31, % 31, % 21, % 0.13% 20, % 17, % 15, % 14, % 11, % % 130, % 122, % 124, % 139, % 163, % 9.55% 1,585, % 1,632, % 1,778, % 1,907, % 2,066, % 19.18% 3,184, % 3,080, % 3,148, % 3,342, % 3,721, % 33.28% 5,523, % 5,392, % 5,596, % 5,946, % 6,496, % 16,598,546 15,127,645 14,989,953 15,181,779 15,559,359
53 51
54 52
55 11,080,026 (100.0) 11,544,549 (100.0) 11,984,728 (100.0) 12,196,271 (100.0) 12,265,485 (100.0) 59,071,059 (100.0) 8,837 (0.08) 32,582 (0.29) 9,493 (0.08) 37,994 (0.33) 10,403 (0.09) 42,263 (0.35) 9,984 (0.08) 47,164 (0.39) 9,773 (0.08) 49,729 (0.41) 48,490 (0.08) 209,732 (0.36) 10,239,806 (100.0) 8,176 (0.08) 27,172 (0.27) 10,463,971 (100.0) 8,839 (0.08) 30,845 (0.29) 11,005,351 (100.0) 9,677 (0.09) 34,439 (0.31) 11,137,174 (100.0) 9,159 (0.08) 37,809 (0.34) 11,001,106 (100.0) 8,560 (0.08) 38,693 (0.35) 53,847,408 (100.0) 44,411 (0.08) 168,958 (0.31) 53 7,454 8,083 8,860 8,430 7,857 40,684 24,786 27,638 30,952 33,924 34, ,143
56
57
58 56
59 57
60 58
61 59
62 60
63 6, ,520(100.0) 2.0( ) ,628(12.4) ,362 78,242(49.4) ,464(10.4) ,726(8.0) ,220 31,459(19.9) ,299 78,224(49.4) ,381 80,255(50.6) ,098 78,621(49.6) ,285 17,932(11.3) ,724(10.6)
64 3,034 71,224 (44.9) 2,082 55,464 (35.0) 1,025 20,024 (12.6) 432 9,329 (5.9) 108 2,480 (1.6) , ,313 (22.0) 52,103 (66.6) 4,765 (28.9) 2,754 (21.6) 7,288 (23.2) ,622 (49.2) 17,878 (22.9) 7,621 (46.3) 6,608 (51.9) 13,736 (43.7) ,594 (8.1) 3,428 (4.4) 2,852 (17.3) 2,857 (22.5) 9,291 (29.5) ,731 (19.0) 4,180 (5.3) 768 (4.7) 345 (2.7) 306 (1.0) (1.9) 654 (0.8) 458 (2.8) 163 (1.3) 837 (2.7)
65 63
66 64
67
68 é ö 66
69 67
70 68
71 282/1,788 (15.8) 57/283 (20.1) 64/2,248 (2.8) 8/64 (13) 162/661 (24.5) 20/181(11) 58/167 (34.7) 1532/27,617 (5.5) 421/1,532 (27.5) 24/242(9.9) 58/1,682 (3.4) 161/579 (27.8) 280/8,061 (3.4) 96/187 (51.3) 317/158,520 (0.2) 69 68/2,575(2.6) 14/69 (20.3) 40/729 (5.5) 55/965 (5.7) 3/55 (5) 49/565(8.7) 33/50 (66) 76/3,238 (2.3) 21/76 (28) 76/400 (19) 12/78 (15) 176/1,562(11.2) 106/280 (38) 34/379 (9) 25/34 (73.5) 96/1,163(8.3) 439/3,904 (11.2) 214/445 (48.1) 55/1458 (3.8)
72 162/718 (22.6) 18/86 (18.9) 3/18 (16.7) 67/219 (30.6) 37/67 (55.2) 86/208 (41.3) 259/2,643(9.8) 159/259 (61.4) 107/797 (13.4) /6,063 (2.9) 43/849 (5.1) 31/293 (10.6) 293/10,184 (2.9) 211/5,757 (3.7) ü 40/1097 (3.6) ó 776/33,975 (2.3) 322/776 (41.5) 42/3,187 (1.3) 32/42 (76.2) 217/13,004(1.7) 22/502 (4.4) 370/1663 (22.2) 150/370 (40.5) 629/18,854 (3.3) 598/90,810 (0.66) 21,298/922,196 (2.3) 53/558(9.5) 44/53 (83) 122/1,017 (12) 83/122 (68) é ö
73 71
74 72
75 18 154, ,
76 59, ( ) 172, ( ) 77, ( ) 36, ( ) 74 4, ( ) 21, ( ) 8, ( ) ( ) 3, ( )
77 75
78 76
79
80 ~
81 79 3,607 (2,618-4,596) 1,547 (1,033-2,060) 4,986 (3,976-5,995) 702 ( ) 1,547 ( ) 2,216 (1,721-2,711) 63 (41-85) 43 (15-71) 106 (76-137)
82 80
83 81
84
85
86
1..
Volume 12, Number 1, 6~16, Factors influencing consultation time and waiting time of ambulatory patients in a tertiary teaching hospital Jee-In Hwang College of Nursing Science, Kyung Hee University :
..........-....33
04 06 12 14 16 18 20 22 24 26 Contents 34 38 42 46 50 54 58 62 66 70 74 78 84 88 90 92 94 96 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 01 26 27 02 28 29 30 31 32 33 34 35 36 37 38 39
자식농사웹완
윤 영 선 _ 지음 은혜한의원 서울시 마포구 도화1동 550 삼성프라자 308호 Tel : 3272.0120, 702.0120 진료시간 : 오전 9시 30분`~`오후 7시 점심시간 : 오후 1시`~`2시 토 요 일 : 오전 9시 30분`~`오후 3시 (일, 공휴일 휴진`/`전화로 진료 예약 받습니다) 은 혜 한 의 원 은혜한의원 CONTENTS 02 04 07
chungo_story_2013.pdf
Contents 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61 63 65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99
Contents 12 13 15 17 70 79 103 107 20 21 24 29 128 137 141 32 34 36 41 46 47 53 55 174 189 230 240 58 61 64 1. 1. 1 2 3 4 2. 2. 2 1 3 4 3. 3. 1 2 3 4 4. 4. 1 2 3 4 5. 5. 1 2 3 1 2 3
전반부-pdf
Contents 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72
<4D6963726F736F667420506F776572506F696E74202D20312E20B0E6C1A6C0FCB8C15F3136B3E2C7CFB9DDB1E25F325FC6ED28C0BA292E70707478>
Contents 3 2016 4 2016 5 2016 6 2016 7 2016 8 2016 9 2016 10 2016 11 2016 12 2016 13 2016 14 2016 15 2016 16 2016 17 2016 18 2016 19 2016 20 2016 21 2016 22 2016 23 2016 24 2016 25 2016 26 2016 27 2016
..........- ........
Contents 24 28 32 34 36 38 40 42 44 46 50 52 54 56 58 60 61 62 64 66 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 01 02 24 25 03 04 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Contents 007 008 016 125 126 130 019 022 027 029 047 048 135 136 139 143 145 150 058 155 073 074 078 158 163 171 182 089 195 090 100 199 116 121 01 01 02 03 04 05 06 8 9 01 02 03 04 05 06 10 11 01 02 03
A°ø¸ðÀü ³»Áö1-¼öÁ¤
1 4 5 6 7 8 9 10 11 Contents 017 035 051 067 081 093 107 123 139 151 165 177 189 209 219 233 243 255 271 287 299 313 327 337 349 12 13 017 18 19 20 21 22 23 24 25 26 27 28 29 30 31 035 051 067 081 093
±¹³»°æÁ¦ º¹»ç1
Contents 2 2002. 1 116 2002. 1 2002. 1 117 118 2002. 1 2002. 1 119 120 2002. 1 2002. 1 121 122 2002. 1 2002. 1 123 124 2002. 1 2002. 1 125 126 2002. 1 2002. 1 127 128 2002. 1 2002. 1 129 130 2002. 1 2002.
¿¡³ÊÁö ÀÚ¿ø-Âü°í ³»Áö.PDF
Contents 01 02 03 6 04 05 7 8 9 01 10 02 03 11 04 01 12 02 13 03 04 14 01 02 03 04 15 05 06 16 07 17 08 18 01 02 03 19 04 20 05 21 06 07 22 08 23 24 25 26 27 28 29 30 31 32 33 01 36 02 03 37 38 01
전반부-pdf
Contents 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72
Microsoft PowerPoint - 3. 2016 하반기 크레딧 전망_V3.pptx
Contents 3 2016 4 2016 5 2016 6 2016 7 2016 8 2016 9 2016 10 2016 11 2016 12 2016 13 2016 14 2016 15 2016 16 2016 17 2016 18 2016 19 2016 20 2016 21 2016 22 2016 23 2016 24 2016 25 2016 26 2016 27 2016
³»Áöc03âš
08 09 27 20 32 42 contents 3 4 5 6 7 8 9 28 10 11 42 38 12 13 45 48 44 14 15 53 50 16 17 58 54 18 19 20 21 22 23 24 25 2008. 5. 27~30 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 2008. 4. 27 42 43 44
¾ç¼º-¾÷¹«Æí¶÷-³»¿ëÃà¼Ò4
contents 6 9 18 21 23 43 44 53 61 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62
전도대회자료집
1 Contents 8 10 57 4 2 63 6 17 43 12 3 4 5 7 6 7 6 8 9 10 11 12 13 14 15 16 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
µ¶ÀÏÅëÀÏÁý1~2Æíq36£02Ð
CONTENTS 3 9 16 20 24 29 33 36 40 48 50 56 60 64 71 76 80 83 88 91 94 97 100 103 106 109 114 116 128 133 139 144 148 151 154 159 170 173 176 181 183 188 190 192 194 198 202 209 212 218 221 228 231 233
양성내지b72뼈訪?303逞
Contents 성매매 예방교육 가이드북 Contents 제3부 성매매의 어제와 오늘 그리고 한국의 현주소 제4부 처벌 과 보호 의 성매매방지법 1. 성매매의 역사적 배경 및 추이 1. 성매매방지법 제정 배경 62 2. 성매매방지법 제정 취지 63 40 2. 성매매에 대한 국가별 개입 양상 42 3. 규범적 판단과 형사처벌을 기준으로 본 성매매 4. 외국의
0204..........1..
contents contents 01 6 7 8 02 9 10 11 12 13 03 14 15 16 17 18 19 20 21 22 23 24 25 26 27 01 30 31 32 33 34 35 36 37 02 38 39 40 41 42 43 44 45 46 03 47 48 49 50 51 52 53 54 55 56 04 57 58 59 60 61
http://www.forest.go.kr 5 2013~2017 Contents 07 08 10 19 20 30 33 34 38 39 40 44 45 47 49 51 52 53 53 57 63 67 Contents 72 75 76 77 77 82 88 93 95 96 97 97 103 109 115 121 123 124 125 125 129 132 137
?덉씠?꾩썐 1
2020 The No.1 Hospital in South - East Korea by 2020 1 2 3 2015 04 08 Contents 10 14 30 04 05 2015 2015 06 07 052)241-1344 08 09 2015 Medical Column 10 11 2015 052)241-1250 12 13 2015 052)241-1235 Medical
?덉씠?꾩썐 1
2014 10 04 06 10 2013. 12 2014. 1 2 3 9 10 Contents 12 22 26 04 05 2014. 10 2014. 10 06 07 2014. 10 08 09 052)241-1241 10 11 2014. 10 Medical Column 052)241-1332 12 13 2014. 10 Medical Column 052)241-1250
?덉씠?꾩썐 1
2014 08 04 06 12 2013. 12 2014. 1 2 3 3 4 7 7 07 Contents 18 20 28 2014. 08 04 05 06 07 2014. 08 052)241-1231 08 09 2014. 08 052)241-1255 2014. 08 10 11 Medical Column 052)241-1241 12 13 2014. 08 Medical
?
Annual Report National Museum of Modern and Contemporary Art, Korea CONTENTS Annual Report National Museum of Modern and Contemporary Art, Korea Annual Report National Museum of Modern and Contemporary
푸른21탄소중립행사내지확정
Carbon Neutral Events / Carbon Free Events Contents 3 11 31 41 47 51 2 01 Part 1 Part. 01 4 Part 1 5 Part 1 6 Part 1 7 Part 1 8 Part 1 9 02 Part 2 Part. 02 12 Part 2 13 Part 2 14 Part 2 15 Part 2 16 Part
21(1)-3(10-64)p fm
w wz 21«1y Kor. J. Clin. Pharm., Vol. 21, No. 1. 2011 3» y t sƒv e z t ½ Á x Á xk w w w (2010 12 31 Á2011 3 11 Á2011 3 13 ) Comparison of Drug Prescriptions Before and AfterG Computerized Drug Utilization
°Ç°�°úÁúº´6-2È£
K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 6 No. 2 www.cdc.go.kr 2013 1 11 6 2 ISSN:2005-811X Flavivirus surveillance in mosquitoes collected from the quarantine
하반기_표지
LEG WORKING PAPER SERIES 2012_ 05 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Á ö 37 38 39 40 41 42 43 44 45 Discussion Paper 49 50 51 LEG WORKING PAPER
02 vol 02 Medical Magazine 03 http://drq.busan.com
2012. vol 2 Medical Magazine 01 02 vol 02 Medical Magazine 03 http://drq.busan.com 04 vol 02 Medical Magazine 05 06 vol 02 Medical Magazine 07 contents Medical Magazine 09 08 vol 02 Medical Magazine 10
歯1.PDF
200176 .,.,.,. 5... 1/2. /. / 2. . 293.33 (54.32%), 65.54(12.13%), / 53.80(9.96%), 25.60(4.74%), 5.22(0.97%). / 3 S (1997)14.59% (1971) 10%, (1977).5%~11.5%, (1986)
*지급결제제도 01_차례
THE BANK OF KOREA 5 6 THE BANK OF KOREA 7 8 THE BANK OF KOREA 9 10 THE BANK OF KOREA 11 12 THE BANK OF KOREA 13 14 THE BANK OF KOREA 15 16 THE BANK OF KOREA 17 18 THE BANK OF KOREA 19 THE BANK OF KOREA
00Àâ¹°
ISSN 1598-5881 REVIEW c o n t e n t s REVIEW 3 4 5 6 7 8 9 10 REVIEW 11 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 REVIEW 37 39 40 41 42 43 44 45 46 47 48 49 50 51 52
00Àâ¹°
ISSN 1598-5881 REVIEW c o n t e n t s REVIEW 1 3 4 5 6 7 8 9 REVIEW 11 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 REVIEW 33 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
2013 <D55C><ACBD><C5F0><BC31><C11C>(<CD5C><C885>).pdf
2013 ANNUAL REPORT Contents 006 007 007 008 009 Part 1 016 017 018 019 020 021 022 023 024 025 026 027 028 029 030 031 032 033 034 035 036 037 038 039 040 041 042 043 044 Part 2 048 049 050 051 052 053
항균제 관리 필요성
6. 3 vincristine 5mg IV order ( ). order... ..,. order.,. 5 20 1. ( 110 74 ).,. 5 45 : Quality of care is the degree to which health services for individuals and populations increase the likelihood of
K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 5 No. 41 www.cdc.go.kr/phwr 2012 10 12 5 41 ISSN:2005-811X Comparison of drug-susceptibility test to the anti-tuberculosis
intro
Contents Introduction Contents Contents / Contents / Contents / Contents / 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
16(1)-3(국문)(p.40-45).fm
w wz 16«1y Kor. J. Clin. Pharm., Vol. 16, No. 1. 2006 x w$btf3fqpsu'psn û w m w Department of Statistics, Chonnam National University Eunsik Park College of Natural Sciences, Chonnam National University
Treatment and Role of Hormaonal Replaement Therapy
Treatment and Role of Hormone Replacement Therapy Chung-Ang University Hospital Chee Jeong Kim 7.2 5.3 6.4 5.6 7.3 5.5 1 1 2 3 4 10 11 7 34 49 122 123 1.0 - - 10. 2001 1998 1998 Improvement of postmenopausal
!! ÒªÛ±‚» (05.1)-PDFøÎ.pdf
Bulletin of Emergency Planning http://www.epc.go.kr C o n t e n t s 69 70 75 78 82 85 86 87 04 88 07 91 20 36 38 46 50 53 4 2005. 1. 71 5 6 7 2005. 1. 71 8 2005. 1. 71 9 1 0 11 2005. 1. 71 1 2 13 2005.
- i - - ii - - iii - - iv - - v - - vi - - 1 - - 2 - - 3 - 1) 통계청고시제 2010-150 호 (2010.7.6 개정, 2011.1.1 시행 ) - 4 - 요양급여의적용기준및방법에관한세부사항에따른골밀도검사기준 (2007 년 11 월 1 일시행 ) - 5 - - 6 - - 7 - - 8 - - 9 - - 10 -
A 617
Special Issue Diabetic Retinopathy Won Ki Lee, M.D. Department of Ophthalmology The Catholic University of Korea College of Medicine Kangnam St. Mary s Hospital E mail : wklee@catholic.ac.kr Abstract R
늘푸른세상4월-136호
2011 04 늘푸른세상4월-136호 2011.3.29 10:54 페이지2 고객과 함께하는 농산업 선도기업-경농 고객상담 080-900-0671 미리매 액상수화제의 특징 원액 그대로 처리하여 간편합니다. 약효지속력과 안전성이 뛰어납니다. 피를 비롯한 일년생잡초에 우수합니다. 올방개 등 다년생잡초의 초기발아를 억제합니다. 설포닐우레아계 제초제에 저항성을 보이는
2015 경제ㆍ재정수첩
Contents 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Part 01 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 Part 02 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62
(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])
![(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])](/thumbs/100/144769741.jpg "(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])")
Cardiovascular Disease in Metabolic Syndrome 김상현 보라매병원내과 서울대학교의과대학내과학교실 Contents Metabolic syndrome and Cardiovascular system CVD Mortality Coronary artery disease Heart failure Atrial fibrillation Management
2018.05 Vol.263 C O N T E N T S 02 06 27 61 68 71 74 78 82 89 99 148 153 155 159 M O N T H L Y P U B L I C F I N A N C E F O R U M 2 2018.5 3 4 2018.5 * 6 2018.5 1) 2) 3) 7 4) 8 2018.5 5) 6) 7) 9 8) 9)
2002 KT
2002 KT 2002 KT { } 4 5 Contents 8 S P E C I A L 9 10 S P E C I A L 11 010110001010100011010110101001101010010101101011100010 01011000101010001101011010100110101 000101010001101011010100110101001010110110111000100101100010
056~064........6..............
병원약사회지(2012), 제 29 권 제 1 호 J. Kor. Soc. Health-Syst. Pharm., Vol. 29, No. 1, 56 ~ 64 (2012) 회원학술보고 신기능에 따른 Sitagliptin의 처방용량 적정성 평가 경성대학교 약학대학 Drug Use Evaluation of Sitagliptin Renal Dosing Kie Ho Sohn
08-ÀåÀμö
25 2 (2004 9 ) J Korean Oriental Med 2004;25(3):78-89 A Review on the Report about Drug-induced Hepatitis published by the National Institute of Toxicological Research Jang Insoo Department of Internal
2012미술관연보_내지_최종.indd
2012 11-1371033-000006-10 2012 Annual Report National Museum of Mordern and Contemporary Art, Korea ANNUAL REPORT 2012 National Museum of Mordern and Contemporary Art, Korea 2012 Contents > 1-1. 8 1-2.
2014 2014 Spring Contents 2014 Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie
Volume 12, Number 1, 92~102, An Intervention Study of Pain Reduction during IV Therapy in Hospitalized Children Myo-Jin Kim 1), Joung-Hae Bak 1), Won-Seok Seo 2) Mi-Young Kim 3), Sun-Kyoung Park 3), Jai-Soung
서론
- i - - ii - - iii - - iv - - v - - vi - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - -
11+12월호(220*270, 36p)최종
www.dcmc.co.kr 2014. 11 / 12 프란치스코 하비에르 원장 신부님! 아 름 다 운 환자 김종양님께서 보내주신 편지글입니다 그리스도 우리의 희망! 감사합니다. 고맙습니다. 프란치스코 하비에르 원장 신부님! 하찮은 노인네 사정을 들어 주시고 배려해 주심에 살아계셔서 저희와 함께 계신 주님 편 지 의 은총을 느꼈습니다. 두 달 동안 정신을
데이터베이스-4부0816
04 269 270 2012 Database White Paper 271 272 2012 Database White Paper 273 274 2012 Database White Paper 275 276 2012 Database White Paper 277 278 2012 Database White Paper 279 280 2012 Database White
122 123
120 121 122 123 124 125 126 127 America Japan England Australia 128 129 China 130 131 BOOK 1 3 4 2 132 133 BOOK 4 1 5 2 6 3 7 134 135 Special Edition 2011 WINTER + Vol.17 302-701 042-481-6379 042-481-6371
표1~4
vol. 123 2012.6. 13 서민과 중소기업을 위해 불공정거래를 개선했습니다 1. LPG, 우유 등 서민생필품 가격담합을 제재했습니다 2. 병 의원의 대규모 리베이트를 근절하고 있습니다 3. 공정거래협약으로 대 중소기업간 동반성장을 촉진했습니다 대통령실 4. 중소기업이 하도급 대금을 제대로 받게 했습니다 5. 마트 등의 입점업체가 불공정으로 피해를 받지
A Problem for Government STAGE 6: Policy Termination STAGE 1: Agenda Setting STAGE 5: Policy Change STAGE 2: Policy Formulation STAGE 4: Policy Evalua
A Problem for Government STAGE 6: Policy Termination STAGE 1: Agenda Setting STAGE 5: Policy Change STAGE 2: Policy Formulation STAGE 4: Policy Evaluation STAGE 3: Policy Implementation 6 Monitor Policy
6À嵶¼º¿¬±¸ºÐ¾ß
Korea Food & Drug Administration 6 01 K o r e a F o o d & D r u g A d m i n i s t r a t i o n 504 505 년들도 친숙하게 독성물질에 대한 정보들에 접근할 수 있도록 하였다. 그림6-1-3 국립독성연구원 홈페이지 K o r e a F o o d & D r u g A d m i n i
00약제부봄호c03逞풚
경희대학교 동서신의학병원 약품 정보지 2 0 0 7. S P R I N G. V O L. 0 1 신약 소개 02 Journal Review 03 Special Subject 04 복약 지도 06 의약품 안전성 정보 07 약제부 알림 07 약제부 업무 소개 08 E A S T - W E S T N E O M E D I C A L C E N T E R 본 약품
untitled
제 1 세부과제 안전한 예방접종 실천을 위한 전략 및 교육, 홍보 자료 개발 제 1 장. 서 론 제 1 절. 연구의 필요성 국가적인 차원에서 예방접종 사업은 전염병 관리를 위한 가장 중요한 방역 사업 중 하나로, 대다수의 전염병 발생률은 각종 전염병의 백신이 나온 후로 현저히 감소하였으며, 인류 역사상 가장 많은 생명을 전염병으로부터 구원해주었다. 그러나,
16(2)-7(p ).fm
w wz 16«2y Kor. J. Clin. Pharm., Vol. 16, No. 2. 2006 ü t xy y w tœ ½ BÁ x BC B y w w w C y w w w Current Status and Expectations of Orphan Drugs in Korea -In point of supplying medicines for the rare
삼성955_965_09
판매원-삼성전자주식회사 본 사 : 경기도 수원시 영통구 매탄 3동 416번지 제조원 : (주)아이젠 삼성 디지털 비데 순간온수 세정기 사용설명서 본 제품은 국내(대한민국)용 입니다. 전원, 전압이 다른 해외에서는 품질을 보증하지 않습니다. (FOR KOREA UNIT STANDARD ONLY) 이 사용설명서에는 제품보증서가 포함되어 있습니다. 분실되지 않도록
Contents 1 01 02 03 04 05 2 06 07 08 09 10 11 12 13 14 15